<div>Dr. George Bakris, of the University of Chicago, discusses the impact of canagliflozin approval and how it impacts the current treatment of diabetic kidney disease. </div>

Dr. George Bakris, of the University of Chicago, discusses the impact of canagliflozin approval and how it impacts the current treatment of diabetic kidney disease.

Dr. George Bakris, of the University of Chicago, discusses the impact of canagliflozin approval and how it impacts the current treatment of diabetic kidney disease.&nbsp;

9: Canagliflozin Approval with Dr. George Bakris

<div>Your destination feed for medical, health care and clinical science podcasts courtesy of HCPLive—featuring our shows Medical Ethics Unpacked, New Insight, and 5 Stories in Under 5.<br>
<br>
<br>
<br>

</div>

News

Science

Medicine

Health & Fitness

Business News

Life Sciences

Your destination feed for medical, health care and clinical science podcasts courtesy of HCPLive—featuring our shows Medical Ethics Unpacked, New Insight, and 5 Stories in Under 5.

Your destination feed for medical, health care and clinical science podcasts courtesy of HCPLive—featuring our shows Medical Ethics Unpacked, New Insight, and 5 Stories in Under 5.<br>
<br>
<br>
<br>



Share 9: Canagliflozin Approval with Dr. George Bakris

Sign up to save your podcasts

9: Canagliflozin Approval with Dr. George Bakris

9: Canagliflozin Approval with Dr. George Bakris

More shows like HCPLive Podcasts

Evidence-Based GI: An ACG Publication and Podcast